Listen to Paul Huckle
& Adrian McKemey - Keynote Speakers at 7th Annual Conference
KEYNOTE
SPEAKER 1
Paul
Huckle
Senior Vice President
Global Regulatory Affairs
GlaxoSmithKline
|
KEYNOTE
SPEAKER 2
Adrian
McKemey
Practice Leader, Product Development
& Commercialization
Quintiles
|
The 7th Annual Conference
this year will begin with Keynote Addresses from Paul Huckle, Senior Vice President, Global
Regulatory Affairs, GlaxoSmithKline and Adrian McKemey, Practice Leader, Product
Development & Commercialization, Quintiles.
The three day conference through 25
sessions and 3 tutorials on the theme 'Innovative Strategies for
Individualized Health Care' will bring together
regulators and pharma professionals working in the discovery,
development, manufacturing or commercialization fields, academicians
working in the fields related to the healthcare industry, finance
professionals working in the healthcare sector and patient advocacy
groups.
To know more on the conference
program here are a few session details.
Scientific, Regulatory
and Ethical Challenges in Advancing Personalized Medicine
This session chaired by Carol Isaacson Barash, Principal, Helix Health
Advisors, Adjunct Prof. Personalized Medicine, Regis College will
discuss
- Realizing the Promise of
Personalization through Healthcare Mass Commercialization by Sagar Kamarthi, Associate Professor,
Department of Mechanical and Industrial Engineering, Northeastern
University, Boston
- Regulatory Challenges for
Molecular and Companion Diagnostics by Jeffrey N. Gibbs, Director
Hyman, Phelps
& McNamara, P. C.
- Ethical Issues in
Individualized Health Care — Seeking Solutions in a Complex World by Aamir Shaikh, Founder Assansa
- Personalized Nutrition:
Parallels from Personalized Medicine by Emanuelle Voisin, CEO and Principal, Voisin
Consulting
Therapeutics —
Pharmacology and Applications in Personalise Medicine
This session chaired by Vishwas Sovani, Country Manager, Revogenex,
Inc. will discuss
- Personalised Medicine
Pharmacological basis by
Vishwas
Sovani,
Country Manager, Revogenex, Inc.
- Therapeutic Applications
of Personalized Medicine by
Mangesh
Kulkarni,
Group Head, DS&E
Novartis
Healthcare
- Ready to use Kits for
Personalized Medicine by
Mukesh
Agrawal,
Vice President - CRL,
Vimta Labs
Personalized Precision
Medicine: Regulatory, Financial and Ethical Challenges to Ensuring its
Growth
This
panel chaired by Carol
Isaacson Barash,
Principal, Helix Health Advisors, Adjunct Prof. Personalized Medicine,
Regis College will consist of the following panelists
- Jeffrey
N. Gibbs,
Director, Hyman, Phelps & McNamara, P. C.
- Arun
Mishra, Director,
Global Regulatory Affairs, Asia-Pacific, Japan, Emerging Markets,
GlaxoSmithKline
- Shoibal
Mukherjee,
Vice President and Head, Asia Medical Sciences Group, Quintiles
- Nandini
K. Kumar,
Former Deputy Director General, Sr. Grade Investigator NIH project,
National Institute of Epidemiology
- Femida
Gwadry-Sridhar,
Director, Health Informatics, Lawson Health Research Institute
- Sagar
Kamarthi,
Associate Professor, Department of Mechanical and Industrial
Engineering
Northeastern
University, Boston
7th Annual
Conference Registration Fees Reduced
Registration fees at the 7th Annual
Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes
to help the industry participate in large numbers and gain immensely
through this unique networking opportunity. Click here
to view the conference program with over 75 International &
India industry leaders.
Follow us and tweet on the 7th
Annual Conference with #DIAIndiaAM2012
Thank You to our 7th
Annual Conference Supporters
Level 2
Level 1
|
No comments:
Post a Comment